Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI

JR Arribas, E DeJesus, J van Lunzen, C Zurawski, M Doroana, W Towner, A Lazzarin, M Nelson, D McColl, K Andreatta, R Swamy, J Szwarcberg, T Nguyen

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI'. Together they form a unique fingerprint.

Medicine & Life Sciences